RNA sequencing reveals the transcriptome profile of the atopic prurigo nodularis with severe itching

Epidemiology of prurigo nodularis in England: a retrospective database analysis

(2022) Christopher L. Morgan et al.   BRITISH JOURNAL OF DERMATOLOGY

Cutaneous Transcriptomics Identifies Fibroproliferative and Neurovascular Gene Dysregulation in Prurigo Nodularis Compared with Psoriasis and Atopic Dermatitis

(2022) Nishadh Sutaria et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Itch intensity in prurigo nodularis is closely related with dermal interleukin‐31, oncostatin M, IL‐31 receptor alpha, and oncostatin M receptor beta

(2021) Takashi Hashimoto et al.   EXPERIMENTAL DERMATOLOGY

Interleukin‐31: The ‘itchy’ cytokine in inflammation and therapy

(2021) Angeliki Datsi et al.   ALLERGY

Long-term Dupilumab Treatment for Chronic Refractory Generalized Prurigo Nodularis: A Retrospective Cohort Study

(2021) Jorge R. Georgakopoulos et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Dupilumab shows slow, steady effectiveness for intractable prurigo in patients with atopic dermatitis

(2021) Satoshi Takeuchi et al.   JOURNAL OF DERMATOLOGY

Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune Polarization

(2021) Micah Belzberg et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Multiple roles of macrophage in skin

(2021) Kozo Nakai   JOURNAL OF DERMATOLOGICAL SCIENCE

The Extracellular Matrix in Skin Inflammation and Infection

(2021) Karin Pfisterer et al.   Frontiers in Cell and Developmental Biology

Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab

(2021) Lam C. Tsoi et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Oncostatin M can sensitize sensory neurons in inflammatory pruritus

(2021) Pang-Yen Tseng et al.   Science Translational Medicine

4-1BBL Regulates the Polarization of Macrophages, and Inhibition of 4-1BBL Signaling Alleviates Imiquimod-Induced Psoriasis

(2020) Haruka Miki et al.   JOURNAL OF IMMUNOLOGY

Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis

(2020) Emma Guttman-Yassky et al.   JAMA Dermatology

Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology Studies

(2020) Edwin Roger Parra et al.   Cancers

Prurigo Nodularis: Epidemiology and Clinical Features

(2020) Amy H. Huang et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Prurigo Nodularis: Pathogenesis and Management

(2020) Kyle A. Williams et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Practical approaches for diagnosis and management of prurigo nodularis: US expert panel consensus

(2020) Sarina Elmariah et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Atopic dermatitis

(2020) Sinéad M Langan et al.   LANCET

Interplay between Cell-Surface Receptors and Extracellular Matrix in Skin

(2020) Svenja Kleiser et al.   Biomolecules

Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients

(2020) Simona Tavecchio et al.   Journal of Clinical Medicine

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study

(2020) C. Patruno et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Atopic dermatitis is an IL-13 dominant disease with greater molecular heterogeneity compared to psoriasis

(2019) Lam C. Tsoi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Activation of Mast-Cell-Expressed Mas-Related G-Protein-Coupled Receptors Drives Non-histaminergic Itch

(2019) James Meixiong et al.   IMMUNITY

Effectiveness of Dupilumab for the Treatment of Generalized Prurigo Nodularis Clinical Phenotype of Adult Atopic Dermatitis

(2019) Maddalena Napolitano et al.   Dermatitis

Atopic dermatitis in diverse racial and ethnic groups-Variations in epidemiology, genetics, clinical presentation and treatment

(2018) Bridget P. Kaufman et al.   EXPERIMENTAL DERMATOLOGY

Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb

(2018) Andreas Wollenberg et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The Genetics of Chronic Itch: Gene Expression in the Skin of Patients with Atopic Dermatitis and Psoriasis with Severe Itch

(2018) Leigh A. Nattkemper et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Ethnic differences and comorbidities of 909 Prurigo Nodularis patients

(2018) Emily Boozalis et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Atopic dermatitis

(2018) Stephan Weidinger et al.   Nature Reviews Disease Primers

European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo

(2017) M.P. Pereira et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

The pathogenesis of Prurigo nodularis - ‘Super-Itch’ in exploration

(2015) C. Zeidler et al.   EUROPEAN JOURNAL OF PAIN

The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization

(2015) Shinji Noda et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Important roles of platelets as immune cells in the skin

(2015) Risa Tamagawa-Mineoka   JOURNAL OF DERMATOLOGICAL SCIENCE

Increased angiogenesis and VEGF expression correlates with disease severity in prurigo patients

(2015) C. Krull et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Effective Control of Recalcitrant Pruritus by Bevacizumab: A Possible Role for Vascular Endothelial Growth Factor in Chronic Itch?

(2013) K Krause et al.   ACTA DERMATO-VENEREOLOGICA

Immunohistochemical analysis of macroautophagy

(2012) Wim Martinet et al.   Autophagy

Cell-Extracellular Matrix Interactions in Normal and Diseased Skin

(2011) F. M. Watt et al.   Cold Spring Harbor Perspectives in Biology